share_log

上交所终止善康医药科创板发行上市审核

The Shanghai Stock Exchange has terminated the review for the listing of Shenzhen Shankang Medical Science and Technology Board.

Breakings ·  Sep 24 17:07

Due to the withdrawal of the application for listing by Shenzhen Shankang Medical Technology Co., Ltd. and its sponsor Sinolink Securities Co., Ltd., the Shanghai Stock Exchange has terminated the review for its Star Market listing.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment